Fed. Circ. Backs Lupin Win In Generic Kidney Drug Case
The Federal Circuit on Thursday affirmed a Delaware federal judge's ruling that Indian generic-drug maker Lupin's version of the kidney disease drug Jynarque does not infringe two patents held by Japanese...To view the full article, register now.
Already a subscriber? Click here to view full article